330
Participants
Start Date
September 15, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
MAGENTIQ-COLO.
This is a diagnostic performance study; no randomization will be conducted. All subjects will undergo the same study procedures. The endoscopist performing the examinations cannot be blinded for the output of the investigational device in this study. Due to the nature of the intervention, it is not guaranteed that the patient is not awake during the procedure, therefore blinding for the patient is also not feasible.
Johns Hopkins Hospital, Baltimore
Erlanger Health System, Chattanooga
Hadassah Medical Organization, Jerusalem
Assuta, Haifa
Erasmus Medical Center, Rotterdam
Magentiq Eye LTD
INDUSTRY